April 13, 2021 — A requirement that mifepristone abortion pills be disbursed only in-person by a medical supplier would perhaps be set apart on care for correct thru the COVID-19 pandemic, the U.S. Meals and Drug Administration says.
The resolution potential that effectively being care services in some states will provide the choice to prescribe mifepristone via telemedicine and mail the pills to sufferers, CBS Files reported.
The American College of Obstetrics and Gynecologists has said the in-person requirement is medically pointless and locations sufferers and medical staff at distress correct thru the pandemic.
In a letter to ACOG, performing FDA Commissioner Janet Woodcock cited four medical publications and wrote, “these studies attain no longer appear to existing increases in serious security concerns… occurring with medical abortion as a outcomes of improving the in-person dispensing requirement correct thru the COVID-19 pandemic,” CBS Files reported.
